BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 2.98% for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2020-03-30
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2018-03-31 was 2.66%, a 15.31% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2017-03-31 was 2.31%, a 8.26% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-03-31 was 2.13%.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2018 was 2.98%, a 29.40% increase from fiscal 2017.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2017 was 2.31%, a 60.14% increase from fiscal 2016.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 1.44%, a 23.40% decline from fiscal 2015.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.88%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | 2.98% 10-K · filed 2020-03-30 | |||||
| 2018-09-30 | 2.79% 10-Q · filed 2019-11-14 | 2.98% 10-Q · filed 2018-11-16 | ||||
| 2018-06-30 | 2.79% 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | 2.66% 10-Q · filed 2019-05-14 | |||||
| 2017-12-31 | 2.31% 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | 2.31% 10-Q · filed 2018-11-16 | |||||
| 2017-06-30 | 2.31% 10-Q · filed 2018-08-14 | |||||
| 2017-03-31 | 2.31% 10-Q · filed 2018-05-15 | |||||
| 2016-12-31 | 1.44% 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | 1.44% 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | 1.44% 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | 2.13% 10-Q · filed 2016-05-13 | |||||
| 2015-12-31 | 1.88% 10-K · filed 2016-03-28 | |||||
| 2015-09-30 | 1.07% 10-Q · filed 2015-11-16 | |||||
| 2010-02-28 | 4.62% 10-Q · filed 2014-11-19 | |||||
| 2006-11-30 | 4.62% 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |